Associate Professor Nick Wilson, Megan Smith (UNSW Australia), Professor Tony Blakely
This blog looks at a study we just published on a cost-utility analysis around extending HPV vaccination to boys in NZ. In a nutshell, it is not currently cost-effective for boys. Here we put these results into a wider context of vaccination – which is often, but not always, a good use of limited health sector resources.